Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT1A receptor agonist
Danijela Piskulic, James S Olver, Paul Maruff, Trevor R Norman
Human Psychopharmacology - Clinical and Experimental | WILEY | Published : 2009
Awarded by Stanley Medical Research Foundation
This research was supported by a grant (02T-135) from the Stanley Medical Research Foundation.